课题基金 / 基金详情

Procaspase 3 activator compounds combined with X-ray irradiation

Procaspase 3 activator compounds combined with X-ray irradiation
Procaspase 3 激活剂化合物与 X 射线照射相结合
批准号:
8349439
负责人:
Karl Haglund
金额:
$11.5万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

Karl Haglund的其他基金

相似基金

相关文献

中文摘要
翻译
我们已经从伊利诺伊大学的合作者那里获得了两种procaspase 3激活剂(PAC-1和PAC-1),并获得了一组细胞系,用于在x射线照射和不照射的情况下测试化合物。对许多肉瘤细胞系进行的初步实验表明,在低密度下,它们不能形成离散的菌落,这表明评价辐射效应的金标准(菌落形成试验)不能直接应用。我们已经评估了其他几种基于磷酸化γ - h2ax组蛋白的测定方法,以量化在缺乏和存在procaspase 3激活剂的情况下辐射的影响。此外,我们正在验证使用基于atp的测定来确定细胞系中的放射致敏活性。这已经取得了重大进展,我们已经开始对细胞系进行明确的分析。这揭示了几个有希望的结果。我们同时也在被研究的细胞系中测试凋亡机制的功能。我们目前正在对每个肉瘤细胞系验证这些检测方法。
英文摘要
We have obtained two procaspase 3 activators (PAC-1 and sPAC-1) from our collaborators at the University of Illinois, and have obtained a panel of cell lines on which to test the compounds with and without X-irradiation. Initial experiments with a number of sarcoma cell lines showed that they did not form discrete colonies when plated at low density, indicating that the gold standard evaluation of the effects of radiation (colony formation assay) could not be applied directly. We have evaluated several other assays based on phosphorylated gamma-H2AX histone proteins to quantitate the effect of radiation in both the absence and presence of procaspase 3 activators. In addition, we are validating the use of an ATP-based assay to determine radiosensitizing activity in cell lines. This has progressed significantly, and we have begun definitive assays on the cell lines. This has revealed several promising results. We are also concurrently testing the function of apoptotic machinery in cell lines under investigation. We are currently validating these assays for each sarcoma cell line.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Procaspase 3 activator compounds combined with X-ray irradiation
Therapeutic use of immunomodulators and ionizining radiation
Procaspase 3 activator compounds combined with X-ray irradiation
Sensitization of chordoma cell lines to ionizing radiation
海外基金